DO
Doximity
DOCS · NYSE
$26.50 -1.27% (-$0.34)
1M +4.78%
Market Cap $4.96B
P/E Ratio 29.67x
Div. Yield -
ROE 16.95%
Bulios Fair Price
$24.52
7.5% downside
Current Price
$26.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DOCS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
48 /100
Fair P/E 29.67x
PEG 0.43x
EV/EBITDA 19.25x
Growth
91 /100
Growing EPS growth 16.61%
Book val. growth 7.21%
Rev. growth 18.41%
Profitability
100 /100
Strong Gross margin 88.07%
FCF margin 45.65%
Net margin 25.48%
Quality
78 /100
Excellent ROIC 15.31%
Asset turnover 0.60x
ROE 16.95%
Debt
100 /100
Low Debt/Equity 0.01x
Net debt/EBITDA -1.08x
Current ratio 6.08x
Stability
74 /100
Stable Beta 1.25x
Profitable years 6
Rev. volatility 4.46%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DOCS
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Jeffrey A. Tangney
Employees
880
Headquarters
San Francisco
Upcoming events
05 NOV
Earnings
Upcoming earnings report